Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic

NCT06226610 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Pruritis

Interventions

DRUG: Dupilumab
OTHER: Placebo

Sponsor

Akron Children's Hospital

Collaborators

[object Object]
[object Object]